EFFECT OF SACUBITRIL/VALSARTAN VS. ENALAPRIL ON CHANGES IN BACKGROUND MEDICAL THERAPY OVER TIME IN THE PARADIGM-HF TRIAL

被引：0
|
作者：
Bhatt, Ankeet [1 ]
Vaduganathan, Muthiah [1 ]
Claggett, Brian [1 ]
Liu, Jiankang [1 ]
Packer, Milton [1 ]
Desai, Akshay S. [1 ]
Lefkowitz, Martin [1 ]
Rouleau, Jean L. [1 ]
Shi, Victor [1 ]
Zile, Michael [1 ]
Swedberg, Karl [1 ]
Vardeny, Orly [1 ]
McMurray, John [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1415-117
引用
收藏
页码：1002 / 1002
页数：1
相关论文
共 50 条
  • [31] Outcomes in patients with and without atrial fibrillation in PARADIGM-HF and effect of sacubitril/valsartan according to atrial fibrillation status
    Mogensen, U.
    Swedberg, K.
    Kober, L.
    Jhund, P.
    Shi, V. C.
    Rouleau, J. L.
    Solomon, S. D.
    Zile, M. R.
    Packer, M.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2016, 37 : 193 - 193
  • [32] VERY LOW DOSE OF SACUBITRIL/VALSARTAN FOR PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION: BEYOND PARADIGM-HF TRIAL
    Kim, Hyoeun
    Oh, Jaewon
    Jang, Ji-Hun
    Kang, Seok-Min
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 955 - 955
  • [33] Effects of sacubitril/valsartan according to background beta-blocker therapy in patients with heart failure and reduced ejection fraction: Insights from PARADIGM-HF
    Gupta, Sharmistha Datta
    Butt, Jawad H.
    McMurray, Eoghan G. M.
    Talebi, Atefeh
    Matsumoto, Shingo
    Rizkala, Adel R.
    Henderson, Alasdair D.
    Desai, Akshay S.
    Lefkowitz, Martin
    Packer, Milton
    Rouleau, Jean L.
    Solomon, Scott D.
    Swedberg, Karl
    Zile, Michael R.
    Jhund, Pardeep S.
    McMurray, John J. V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024,
  • [34] Effects of Sacubitril/Valsartan on Physical and Social Activity Limitations in Patients With Heart Failure A Secondary Analysis of the PARADIGM-HF Trial
    Chandra, Alvin
    Lewis, Eldrin F.
    Claggett, Brian L.
    Desai, Akshay S.
    Packer, Milton
    Zile, Michael R.
    Swedberg, Karl
    Rouleau, Jean L.
    Shi, Victor C.
    Lefkowitz, Martin P.
    Katova, Tzvetana
    McMurray, John J., V
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2018, 3 (06) : 498 - 505
  • [35] EFFECTS OF SACUBITRIL/VALSARTAN OR VALSARTAN IN DE NOVO VS. CHRONIC HFPEF AND HFMREF: THE PARAGLIDE-HF TRIAL
    Murray, Evan
    Cyr, Derek D.
    Morrow, David A.
    Starling, Randall C.
    Zieroth, Shelley R.
    Hernandez, Adrian F.
    Williamson, Kristin
    Lepage, Serge
    Fudim, Marat
    Desai, Akshay S.
    Ward, Jonathan
    Solomon, Scott D.
    Mentz, Robert John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4607 - 4607
  • [36] Cardiac and Noncardiac Disease Burden and Treatment Effect of Sacubitril/Valsartan Insights From a Combined PARAGON-HF and PARADIGM-HF Analysis
    Rohde, Luis E.
    Claggett, Brian L.
    Wolsk, Emil
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean
    Pfeffer, Marc A.
    Desai, Akshay S.
    Lund, Lars H.
    Kober, Lars
    Anand, Inder
    Merkely, Bela
    Senni, Michele
    Shi, Victor
    Rizkala, Adel
    Lefkowitz, Martin
    McMurray, John J., V
    Solomon, Scott D.
    CIRCULATION-HEART FAILURE, 2021, 14 (03) : 361 - 371
  • [37] Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients
    Campanile, Alfonso
    Visco, Valeria
    De Carlo, Stefania
    Ferruzzi, Germano Junior
    Mancusi, Costantino
    Izzo, Carmine
    Mongiello, Felice
    Di Pietro, Paola
    Virtuoso, Nicola
    Ravera, Amelia
    Bonadies, Domenico
    Vecchione, Carmine
    Ciccarelli, Michele
    LIFE-BASEL, 2023, 13 (05):
  • [38] Risk of cardiovascular death and hospitalization for heart failure with sacubitril/valsartan versus enalapril in clinical practice: Application of outcome models developed with clinical trial data from PARADIGM-HF
    Shin, Hojin
    Patorno, Elisabetta
    Schneeweiss, Sebastian
    Wang, Shirley V.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 276 - 276
  • [39] Clinical Role of Sacubitril/valsartan Therapy in Heart Failure With Reduced Ejection Fraction Patients With End Stage of Renal Disease; Beyond PARADIGM-HF Trial
    Lee, Seonhwa
    Oh, Jaewon
    Ha, Jaehyung
    Chun, Kyeong-Hyeon
    Kim, Hyoeun
    Lee, Chan Joo
    Park, Sungha
    Lee, Sang-Hak
    Kang, Seok-Min
    CIRCULATION, 2019, 140
  • [40] Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
    Mogensen, Ulrik M.
    Gong, Jianjian
    Jhund, Pardeep S.
    Shen, Li
    Kober, Lars
    Desai, Akshay S.
    Lefkowitz, Martin P.
    Packer, Milton
    Rouleau, Jean L.
    Solomon, Scott D.
    Claggett, Brian L.
    Swedberg, Karl
    Zile, Michael R.
    Mueller-Velten, Guenther
    McMurray, John J., V
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (04) : 760 - 768
12345